pharma · Prostate Cancer · Autoimmune · JANX
Janux Therapeutics
Janux Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
San Diego, USA HQ
2017 Founded
110 Employees
Public company Type
JANX · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2017
- Employees
- 110
- Programs
- 4
- Drugs
- 0
- Patents
- 2
Janux Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Janux Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.